What type of study is this?

September 5, 2025Open Access

Supplementary Figure S4 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer

View Full Paper

Ask AI

Bookmark

Authors

Analysis shows reduced tumor growth and inflammation in lung cancer models with RORγt inhibition, suggesting a therapeutic potential.

Inhibition of RORγt significantly reduces tumor growth in lung cancer models, improving outcomes.
Observations indicate that LUAD cell line proliferation and viability remain unchanged by RORγt inhibition.
Experimental models demonstrate decreased protumor inflammation with RORγt pharmacological inhibition.
These findings highlight the potential for targeting RORγt in lung cancer therapies.

Yamada‐Hara et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark